The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Topic:
Medication for Opioid Use Disorder (MOUD)
Pharmacology/Prescribing
Substance/Stimulant/Opiod Use Disorder
Pharmacology/Prescribing
Substance/Stimulant/Opiod Use Disorder
Setting:
FQHC
OBOT
Outpatient
Primary Care
OBOT
Outpatient
Primary Care
Type: Best Practice/Policy/Guideline/Procedure